Topiramate medicine composition
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BEIJING WINSUNNY PHARMA CO LTD
- Publication Date
- 2013-12-04
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
[0001] technical field
[0002] The invention relates to a topiramate pharmaceutical composition and a preparation method thereof, belonging to the field of pharmaceutical preparations. Background technique
[0003] Epilepsy is a neurological disease, usually brain dysfunction caused by sudden abnormal excessive discharge of brain cells caused by brain lesions. It is estimated that the incidence of epilepsy in different populations around the world is about 0.3% to 0.5%, and the prevalence is about With 5 to 10 people in every 1000 people, epilepsy seriously threatens people's health and affects people's daily life.
[0004] Topiramate, a new type of antiepileptic drug that replaces monosaccharides with sulfamic acid esters, was developed by Johnson & Johnson in the United States and was launched in the UK under the trade name Topamax in 1995. In the electrophysiological and biochemical studies on neurons cultured in vitro, it was found that there are three mechanisms for t...